✦ LIBER ✦

Long-Term Clinical Value of Telaprevir for Treatment of Treatment-NaïVE and Treatment-Experienced Patients With Hepatitis C Virus (HCV) Infection: Projections Using Decision-Analytic Modeling

✍ Scribed by Brogan, Anita J. ;Miller, Jeffrey D. ;Talbird, Sandra E. ;Thompson, James R. ;Deniz, Baris

Book ID: 122201129
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 469 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63926-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

982 Cost-Effectiveness of First-Line Ver

982 Cost-Effectiveness of First-Line Versus Second-Line Telaprevir Combination Treatment in the Management of Chronic Hepatitis C Virus Infection for Treatment-NaïVE Patients With IL28B Genotype CC

✍ Anita Brogan; Sandra E. Talbird; James R. Thompson; Jeffrey D. Miller; Shelley G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

A Decision Analytic Markov Model to Eval

A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options with Chronic Hepatitis C Virus Genotype 2 Infection

✍ Younossi, Z.M.; Gordon, S.; Saab, S.; Ahmed, A.; Cure, S.; Guerra, I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Early viral kinetics and treatment outco

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load

✍ Akihito Tsubota; Yasuji Arase; Takashi Someya; Yoshiyuki Suzuki; Fumitaka Suzuki 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## Abstract An investigation was carried out to determine whether early viral monitoring could predict efficiently the virological response to combination therapy of two different regimens in treatment‐naïve chronic hepatitis C patients infected with genotype 1b with high baseline viral load. Patie

PIN73 Modeling the Long Term Clinical Ou

PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UK

✍ P.O. Thuresson; B. Verheggen; B. Heeg; I. Aldir; J. Carrasco; G. Didoni; O.A. Me 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB